患有炎症性关节炎的个体是否接受对发生抑郁和焦虑的最低足够治疗:基于人口的研究
Alyssa Howren1,2,3, Eric C Sayre4, J Antonio Avina-Zubieta3,5
1Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
Arthritis research & therapy
|January 22, 2025
概括
患有炎症性关节炎 (IA) 的个人经历的抑郁和焦虑率与一般人群相似,但往往接受不充分的心理健康治疗. 将公共资助的医疗保健扩大到包括心理健康服务,对于解决这些未满足的需求至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 精神病学是一个精神病学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 患有炎症性关节炎 (IA) 的人经常经历并发性抑郁和焦虑.
- 了解IA中精神健康状况的治疗模式对于改善患者结果至关重要.
- 目前的文献缺乏对抑郁症/焦虑症IA患者的药物治疗和心理治疗充足性的全面分析.
研究的目的:
- 描述IA患者发生抑郁和焦虑的药物治疗和心理治疗模式.
- 评估IA患者接受的抑郁症和焦虑症最低足够的治疗,与没有IA的患者相比.
- 为了识别潜在的差异在精神卫生保健提供给IA的个人.
主要方法:
- 使用了来自加拿大不列颠哥伦比亚省的基于人口的链接行政健康数据库.
- 至少充足的药物治疗被定义为≥84天的抗抑郁药物供应.
- 足够的心理治疗被定义为≥4个咨询/心理治疗服务.
- 多变量逻辑回归模型比较了IA患者和IA无控制组之间接受治疗的情况.
主要成果:
- 50.5%的IA患者接受了适度的抑郁药物治疗,19.6%接受了足够的心理治疗,类似于没有IA的对照组.
- 对焦虑的治疗适度在IA患者和对照人群之间也是可比的.
- IA患者显示,使用二胺和三环抗抑郁药处方的可能性更高,二胺供应持续时间更长.
结论:
- 很大一部分患有AI的人没有接受足够的心理健康治疗抑郁症和焦虑症,反映了一般人群中的比例.
- 在IA中精神健康障碍的治疗不足对类风湿病的护理有负面影响.
- 扩大公共资助的医疗保健以整合心理健康服务对于解决未满足的咨询需求至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Inflammatory Bowel Disease IV: Pharmacological Management
109
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
109
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Antidepressant Drugs: MAOIs and Other Agents
185
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
185
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
314
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
314


